In a ruling that could have "far-reaching" implications for genetic research and the medical industry, a U.S. District Judge Robert Sweet on Monday invalidated seven patents related to the BRCA1 and BRCA2 genes, mutations of which have been linked to breast and ovarian cancer, the New York Times reports (Pollack/Schwartz, New York Times, 3/29)...